LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
61.95 USD
-0.74%
Market Closed
Updated:
May 10, 2024
LivaNova PLC
Other Current Liabilities
|
LivaNova PLC
Other Current Liabilities Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Other Current Liabilities
$58m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Other Current Liabilities
$451m
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Other Current Liabilities
$22.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Other Current Liabilities
£504k
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-19%
|
|
|
Angle PLC
LSE:AGL
|
Other Current Liabilities
£439k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Other Current Liabilities
£4m
|
CAGR 3-Years
357%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Other Current Liabilities?
Other Current Liabilities
58m
USD
58m
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Other Current Liabilities amounts to 58m USD.
What is LivaNova PLC's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-26%
-26%
Over the last year, the Other Current Liabilities growth was -10%. The average annual Other Current Liabilities growth rates for LivaNova PLC have been -11% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
